Tamoxifen As A Breast Cancer Preventive — Mixed Results In Long-Term Follow-Up
The IBIS-1 trial shows a dramatic, reductive effect of tamoxifen in preventing breast tumors.
What’s Intriguing And Concerning About Early Results For Keytruda In Breast Cancer
What’s concerning about the preliminary findings is that the median time to response was 18 weeks. For patients to wait four months or longer to see if there’s a benefit seems like a lot; these are women without much time to spare.
To Address Breast Cancer Globally, 3 Things Are Essential
First, you need awareness. In many world regions, fatalism is still an obstacle. Second, you need a delivery system. Third…
So What About That Acrylamide In Your French Fries?
In 2002, scientists reported that acrylamide forms when seemingly healthy carbohydrate-rich foods like potatoes, other root vegetables and grains are cooked at high temperatures by frying, roasting, broiling, toasting or baking.
Collateral Damage: How A Cancer Diagnosis Hurts Employment And Finances
Employment and money concerns haunt many people with all kinds of cancer, nation-wide, during and after treatment.
At Palliative Care In Oncology Symposium, A Burst Of Energy
“There is no ‘race for the palliation,’” said Dr. Michael Levy, MD, PhD of Fox-Chase Cancer Center, a palliative care specialist.
The (Unmet) Potential Value of Cancer Genome Testing
Genome sequencing is not routine in oncology practice. But maybe it should be, advocates suggest.
Ebola, Experimental Drugs and Informed Consent: Should Those At Risk Simply Take What The Doctor Orders?
Is it possible to apply the principle of informed consent when giving experimental drugs during a rapid and devastating epidemic?
Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer
The Lung-MAP trial will identify molecular abnormalities in tumors specimens from thousands of patients with squamous cell lung cancer.
Unlocking the Mystery of Cancer Stem Cells
Scientists research whether cancer stem cells are the key to eradicating the disease.
What’s Missing in the Recent Mammography Value Study
It’s precisely because there are effective treatments for early-stage disease that it’s worth finding breast cancer early.